This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Commissariat a L'energie Atomique Et Aux Energies Alternatives, National Institute of Health and Medical Research. Active years: 2018-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 5,383 
2 out of 8,845 
2 out of 1,853 
Years Active: 2018-2021
Title: Mickael Audrain: Innovator in Alzheimer's Disease Research
Introduction
Mickael Audrain is a notable inventor based in Le Kremlin Bicetre, France. He has made significant contributions to the field of Alzheimer's disease research, holding 2 patents that focus on innovative methods for studying this complex condition. His work aims to advance the understanding and treatment of Alzheimer's disease.
Latest Patents
Mickael Audrain's latest patents include a groundbreaking invention related to an Alzheimer's disease animal model. This invention involves a vector comprising a nucleic acid sequence that encodes the APP protein and/or the PS1 protein or variants thereof. The patent also describes a method for inducing Alzheimer's disease in an animal using this vector, as well as the resulting animal model that exhibits the disease.
Career Highlights
Throughout his career, Mickael has worked with prestigious organizations such as the Commissariat à l'Énergie Atomique et aux Énergies Alternatives and the Centre National de la Recherche Scientifique. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in Alzheimer's research.
Collaborations
Mickael has collaborated with notable colleagues, including Nathalie Cartier-Lacave and Nicole Deglon. These partnerships have enriched his research and fostered a collaborative environment for innovation.
Conclusion
Mickael Audrain's work in Alzheimer's disease research exemplifies his commitment to advancing scientific knowledge and developing effective models for studying this challenging condition. His patents and collaborations highlight his role as a key innovator in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile